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Substantia nigra dopaminergic neuron
Mitochondrial membrane potential
Mitochondrial fragmentation
Reactive oxygen speciesMutations in PTEN-induced kinase 1 (PINK1) gene cause recessive familial type 6 of Parkinson's disease
(PARK6). PINK1 is believed to exert neuroprotective effect on SN dopaminergic cells by acting as a
mitochondrial Ser/Thr protein kinase. Autosomal recessive inheritance indicates the involvement of loss of
PINK1 function in PARK6 pathogenesis. In the present study, confocal imaging of cultured SN dopaminergic
neurons prepared from PINK1 knockout mice was performed to investigate physiological importance of
PINK1 in maintaining mitochondrial membrane potential (ΔΨm) and mitochondrial morphology and test the
hypothesis that PARK6 mutations cause the loss of PINK1 function. PINK1-deﬁcient SN dopaminergic neurons
exhibited a depolarized ΔΨm. In contrast to long thread-like mitochondria of wild-type neurons, fragmented
mitochondria were observed from PINK1-null SN dopaminergic cells. Basal level of mitochondrial superoxide
and oxidative stressor H2O2-induced ROS generation were signiﬁcantly increased in PINK1-deﬁcient
dopaminergic neurons. Overexpression of wild-type PINK1 restored hyperpolarized ΔΨm and thread-like
mitochondrial morphology and inhibited ROS formation in PINK1-null dopaminergic cells. PARK6 mutant
(G309D), (E417G) or (CΔ145) PINK1 failed to rescuemitochondrial dysfunction and inhibit oxidative stress in
PINK1-deﬁcient dopaminergic neurons. Mitochondrial toxin rotenone-induced cell death of dopaminergic
neurons was augmented in PINK1-null SN neuronal culture. These results indicate that PINK1 is required for
maintaining normal ΔΨm and mitochondrial morphology of cultured SN dopaminergic neurons and exerts its
neuroprotective effect by inhibiting ROS formation. Our study also provides the evidence that PARK6 mutant
(G309D), (E417G) or (CΔ145) PINK1 is defective in regulating mitochondrial functions and attenuating ROS
production of SN dopaminergic cells., Chang Gung University School
).
ll rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Patients with familial type 6 of Parkinson's disease (PARK6) exhibit
early-onset parkinsonism symptoms and autosomal recessive inheri-
tance [1]. Subsequent molecular genetic studies demonstrated that
homozygous missense or truncatingmutations of PTEN-induced kinase
1 (PINK1) gene are implicated in the pathogenesis of PARK6 and that
PINK1 is the second most frequent causative gene in early-onset
Parkinson's disease (PD) [2–7]. PINK1was initially discovered as one of
the transcriptionally activated genes by tumor suppressor PTEN
(phosphatase and tensin homolog deleted on chromosome 10) [8].
PINK1mRNA is ubiquitously expressed with an abundant expression in
brain, heart, skeletal muscle and testis [8]. Within the brain, PINK1mRNA is mainly found in neurons with little expression in glial cells. A
high level of neuronal PINK1 expression is observed in the substantia
nigra, neocortex and hippocampus [9,10]. PINK1 contains 581 amino
acids and consists of an N-terminal mitochondrial targeting motif, a
possible transmembrane domain, a Ser/Thr kinase domain and a C-
terminal autoregulatory domain [11–13]. N-terminal mitochondrial
targeting sequence is sufﬁcient for the mitochondrial import of PINK1
protein [12,14]. Within the mitochondria, PINK1 is expressed in the
mitochondrial intermembrane space, inner and outer mitochondrial
membranes [10,12,15,16].
Mitochondria play a critical role in the ATP production, calcium
homeostasis, oxidative stress response and initiation of cell death
process [17]. Multiple lines of evidence indicate that mitochondrial
dysfunction is involved in the neurodegeneration of substantia nigra
pars compacta (SNpc) dopaminergic cells in PD patients [18–20].
Impaired activity of complex I and increased levels of oxidative stress
products were found in the substantia nigra of PD patients [20].
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caused cell death of SNpc dopaminergic neurons by activating
mitochondrial apoptotic pathway and were used to prepare PD animal
model [18,20]. Homozygous mutations of PINK1 gene cause autosomal
recessive PD, and the sequence of Ser/Thr kinase is the only functional
domain in PINK1 protein. Therefore, PINK1 is believed to regulate
mitochondrial functions of SNpc dopaminergic neurons and exert
neuroprotective effect against various cellular stresses by functioning as
a mitochondrial Ser/Thr protein kinase [2,7,13,16]. In accordance with
this hypothesis, previous studies using cell lines,Drosophila or zebraﬁsh
model showed that PINK1 is involved in maintaining the normal
function and structural integrity of mitochondria. Deletion of PINK1
gene in Drosophila muscles caused defects in mitochondrial morphol-
ogy, an impaired ATP production and a reduction inmitochondrial DNA
and protein levels [21,22]. PINK1 knockdown in zebraﬁsh resulted in
impairedmitochondrial functions, including depolarizedmitochondrial
membrane potential and increased reactive oxygen species (ROS) level,
and a decrease in the number of central dopaminergic neurons [23].
Knockdown of PINK1 expression by RNA interference in HeLa cells or
dopaminergic neuroblastoma cell line led to depolarization of mito-
chondrial membrane potential and truncated or fragmentedmitochon-
drial morphology [24–29]. PINK1 is the ﬁrst protein directly linking the
mitochondrial abnormality to the neurotoxicity of SN dopaminergic
cells and PD pathogenesis. Therefore, it is essential to investigate PINK1
regulation of mitochondrial function and morphology using SN
dopaminergic neurons.
The autosomal recessive inheritance indicates that PARK6mutation-
induced loss of PINK1 function is involved in PARK6pathogenesis.Wild-
type PINK1 is believed to be required for maintaining normal
mitochondrial functions of SN dopaminergic neurons and exert a
neuroprotective effect [7,13,16]. PARK6 PINK1 mutations could impair
the ability of PINK1 to maintain mitochondrial function and cause the
loss of PINK1-mediated neuroprotective effect, which subsequently
leads to the neurotoxicity of SN dopaminergic cells. Consistent with this
hypothesis, our previous study demonstrated that when expressed in
cell lines, mitochondrial PINK1 produces a cytoprotective effect by
inhibiting apoptotic stimuli-induced opening of mitochondrial perme-
ability transition pore, cytochrome-c release and subsequent caspase-3
activation [14]. In contrast, several PARK6 PINK1 mutants expressed in
cell lines failed to inhibit mitochondrial release of cytochrome-c and
exert anti-apoptotic effect [2,14,30]. However, PARK6 mutations-
induced loss of PINK1-mediated mitochondrial and neuroprotective
functions in SN dopaminergic neurons should be further conﬁrmed. To
better understand physiological functions of PINK1 in SN dopaminergic
cells and molecular pathogenesis of PARK6, in the present study
cultured SNdopaminergic neurons prepared fromPINK1knockoutmice
were used to investigate physiological importance of PINK1 in
maintaining mitochondrial function and morphology and test the
hypothesis that PARK6 mutations cause the loss of PINK1 function.
2. Materials and methods
2.1. Generation of PINK1-deﬁcient mice
BAC clone containing the mouse PINK1 gene was obtained from
Invitrogen. To target the exon 1 of PINK1, 1.1- and 5.9-kb DNA fragments
surrounding the exon 1 were prepared by performing PCR ampliﬁcation
with BAC clone DNA and used as the 5′ and 3′ homologous sequences,
respectively. The 5′ homologous arm corresponds to the 5′ region of exon
1, and the 3′ homologous arm spans 3′ terminal portion of exon 1 to the
exon 3 of PINK1 gene. Target vector of PINK1 gene was constructed by
subcloning 5′ and 3′ homologous DNA fragments into pBluescript vector
containing the PGK-Neo selection cassette. The linearized target vector
was transfected by electroporation into mouse ES cells derived from the
129/Sv strain. Neomycin-resistant colonies were obtained, and Southern
blot analysis described below was performed to select ES cell lines withcorrect homologous recombination of target vector. Correctly targeted ES
clone was injected into C57BL/6J blastocysts. The resulting chimeric mice
were mated with C57BL/6J mice and bred to obtain F1 heterozygous
mutant mice. PINK1−/−mice withmixed genetic backgrounds of C57BL/
6J and 129/Sv strains were obtained by the interbreeding of F1
heterozygous mice.
2.2. Southern blot analysis
Genomic DNA was digested with XbaI, electrophoresed in 0.8%
agarose gel, and transferred toHybondN+ ﬁlter. The blotwas hybridized
with 3′ external DNA probe (~600 bp) radiolabeled by random priming
at 65 °C for 16–18 h. Then, the blotwaswashed (0.5× SSCwith 0.1% SDS)
at 65 °C and exposed to X-rayﬁlm. The expected sizes ofXbaI fragment in
wild-type allele and targeted allele are 16 and 9 kb, respectively.
2.3. Northern blot analysis and RT-PCR assay of PINK1 mRNA expression
Total RNA was prepared from the brain of wild-type, PINK1+/− or
PINK1−/−mouse by using Trizol Reagent (Invitrogen), electrophoresed
in 1% formaldehyde agarose gel, and transferred to Hybond N+ ﬁlter.
The blot was hybridized with radiolabeled DNA probe (~600 bp)
corresponding to C-terminal fragment of human PINK1 cDNA at 65 °C
for 16–18 h. Then, the blot was washed at 65 °C and exposed to X-ray
ﬁlm. The expected size of PINK1mRNA transcript is 2.3 kb. As a control,
the blot was also hybridized with DNA probe speciﬁc for mRNA
encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
For RT-PCR analysis, the ﬁrst-strand cDNA was synthesized in a
reaction volume of 30 μl containing total RNA (5 μg), 1× the ﬁrst-
strand buffer, 10 mM dithiothreitol, 1 mM of each dNTP, 10 ng/μl
random hexamers, 20 U of RNAse inhibitor (Promega) and 100 U of
SuperScript III RT (Invitrogen) for 1 h at 50 °C. Subsequently, the
reactionmixturewas heated at 70 °C for 15min, chilled on the ice, and
used as DNA template for PCR ampliﬁcation. PCR ampliﬁcation of
PINK1 cDNA was performed with forward primer (5′TGATGTGGAA-
TATCTCGGCAGGTTC3′) and reverse primer (5′ACACTCCAGGT TAGC-
CAGAAACAGC3′). The expected size of PINK1 cDNA fragment is 1050
bp. PCR ampliﬁcation of GAPDH mRNA was used as the control.
2.4. Preparation and immunoﬂuorescence staining of cultured substantia
nigra neurons
Cultured substantia nigra (SN) neurons were prepared as described
previously [31]. Brieﬂy, substantia nigrawas dissected frompostnatal 3-
or 4-day-old wild-type or PINK1−/− mice and incubated with DMEM/
F12 medium containing pronase (0.5 mg/ml, Roche) and DNase I (0.3
mg/ml, Roche) for 50min at 37 °C. Tissue fragments were subsequently
triturated, and dissociated cells were plated onto poly-L-lysine- and
collagen-coated dishes. SN neurons were cultured in DMEN/F12
medium supplemented with 5% fetal bovine serum, 3% horse serum
andGDNF(glial cell line-derivedneurotrophic growth factor; 25ng/ml).
From the secondday in culture, proliferation of glial cells was prevented
by adding 5′-ﬂuoro-2′-deoxyuridine and uridine into culture medium.
Cultured SN neurons were ﬁxed with 4% paraformaldehyde,
permeabilized in 0.1% Triton x-100, and then incubated at 4 °C overnight
with diluted monoclonal anti-tyrosine hydroxylase antibody (Chemi-
con). Following thewash, neuronswere incubatedwith FITC-conjugated
horse anti-mouse IgG (Vector). Then, dopaminergic neurons were
viewed and photographed under a Leica DM LFSA upright microscope
equipped with Epiﬂuorescence system.
2.5. Confocal imaging of mitochondrial membrane potential and reactive
oxygen species (ROS) formation
For the determination ofmitochondrial membrane potential (ΔΨm),
cultured SNdopaminergic neurons ofwild-type or PINK1−/−micewere
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methyl ester; 100 nM;Molecular Probes) inHEPES buffered saline (NaCl
140 mM, KCl 5 mM, MgCl2 1 mM, CaCl2 2 mM, glucose 10mM, HEPES 5
mM, pH 7.3) for 10 min at room temperature. SN neurons were then
washed with HEPES buffered saline, and transferred to the recording
chamber mounted on a Leica DM6000 microscope equipped with Leica
TCS SP5 confocal spectral scanning system and a 100× oil immersion
objective. TMRMwasexcitedat543nmwithaHeNegreen laser, and the
emitted ﬂuorescent signal (emission, 560–620 nm) was collected. Z-
stacks of 15 confocal TMRM ﬂuorescence images (with an acquisition
interval along the z-axis of 0.3 μm)were processed and analyzed by LAS
AF software (Leica).
Confocal MitoSOX Red staining was performed to visualize mito-
chondrial level of superoxide anion in wild-type or PINK1-deﬁcient SN
dopaminergic neurons. MitoSOX Red selectively targeted to the
mitochondria is oxidized by superoxide and exhibits red ﬂuorescence.
Cultured SN neurons were incubated with 5 μM MitoSOX Red
(Molecular Probes) for 10 min at 37 °C. After washout, MitoSOX Red
was excited at 514 nm with an Ar-blue laser, and ﬂuorescence signal
was detected (emission, 540–620 nm).
To visualize oxidative stressor H2O2-induced formation of intracel-
lular reactive oxygen species (ROS), wild-type or PINK1−/− SN
dopaminergic neurons were loaded with 1 μM CM-H2DCFDA (5-(and-
6)-chloromethyl-2′,7′-dichlorodihydroﬂuorescein diacetate, acetyl
ester; Molecular Probes), which becomes intensely ﬂuorescent after
being oxidized by intracellular ROS, for 40 min at room temperature.
Following the washout, CM-H2DCFDA signal was detected by 488 nm
excitation using Ar-blue laser, and the emitted ﬂuorescence (emission,
510–560nm)was collected.MitoSOXRedorCM-H2DCFDAﬂuorescence
images were analyzed by Leica LAS AF software.
2.6. Confocal imaging of mitochondrial morphology
To visualize mitochondrial morphology, cultured wild-type or
PINK1-deﬁcient SN dopaminergic neurons were incubated with
Mitotracker Green (150 nM; Molecular Probes) for 15 min at room
temperature. Mitotracker Green is a cell-permeable mitochondrial-
speciﬁc dye and becomes ﬂuorescent when associated with lipids
within themitochondria. After being loadedwithMitotracker Green, SN
neuronswerewashedwithHEPES buffered saline and transferred to the
recording chamber for confocal microscopy observation. Mitotracker
Green was excited at 488 nm with an Ar-blue laser, and ﬂuorescent
image was detected. Confocal Mitotracker Green images were analyzed
by LAS AF software (Leica).
2.7. Preparation of recombinant adenoviruses containing cDNA of
wild-type or PARK6 mutant PINK1
Inﬂuenza hemagglutinin epitope (HA, YPYDVPDYA) was added to
the C-terminus of human wild-type PINK1 by performing PCR
ampliﬁcation. Oligonucleotide-directed mutagenesis using PCR am-
pliﬁcation was performed to prepare cDNA encoding PARK6 mutant
PINK1 [14]. According to our previous studies [31,32], AdEasy
Adenoviral Vector System (Stratagene) was used to prepare recom-
binant adenoviruses containing cDNA of wild-type or PARK6 mutant
PINK1 by homologous recombination. Brieﬂy, cDNA of HA-tagged
wild-type or mutant PINK1 was subcloned into pShuttle vector
provided in the kit. The resulting plasmid was cotransformed into E.
coli BJ5183 cells with adenoviral backbone plasmid pAdEasy-1.
Recombinant adenoviral plasmid was then transfected into HEK 293
cells, which provide E1 gene required for the production of infectious
viral particles. Following the ampliﬁcation in HEK 293 cells, viral
stocks were puriﬁed by CsCl gradient ultracentrifugation and titered
using Adeno-X rapid titer kit (Clontech). One day after plating,
cultured SN neurons were infected with recombinant adenovirus at
multiplicity of infection (MOI) of 20–30 pfu/cell.2.8. Western blot analysis of HA-tagged PINK1 expressed in cultured SN
neurons
Following the infection of adenoviruses containing cDNA of wild-
type or PARK6 mutant PINK1, mitochondrial and cytosolic fractions of
cultured SNneuronswereprepared asdescribedpreviously [14]. Brieﬂy,
SN neurons were lysed in ice-cold buffer containing 210 mMmannitol,
70 mM sucrose, 10mMHEPES, pH= 7.3, 1 mM EGTA, 1 mMDTT, 5 μg/
mlpepstain, 5 μg/ml leupetin, 5 μg/ml aprotinin, and0.3mMPMSF. Cells
were homogenized using a Dounce tissue grinder on ice, and cell lysate
was centrifuged at 500 × g for 10 min at 4 °C. The supernatant was
centrifuged at 9500 × g for 9 min at 4 °C to pellet the mitochondrial
fraction. The resulting supernatantwas further centrifuged at 16,000× g
for 20 min at 4 °C, and ﬁnal supernatant was used as cytosolic fraction.
Protein samples were fractionated on 10% SDS-polyacrylamide and
transferred to polyvinylidene diﬂuoride (PVDF) membrane. Subse-
quently, the membrane was incubated with diluted polyclonal anti-HA
antiserum (Santa Cruz) overnight at 4 °C. Then, the membrane was
incubated with donkey anti-rabbit horseradish peroxidase-linked
secondary antibody (Amersham). Subsequently, immunoreactive pro-
teins on the membrane were visualized by using enhanced chemilumi-
nescence protocol (ECL Kit, Amersham). To verify the purity of
mitochondrial fraction, membrane was stripped and reblotted with
monoclonal anti-cytochrome c oxidase subunit IV (COX-IV), a mito-
chondrial marker (Molecular Probes).
2.9. Analysis of neuronal death
Two days after treating cultured SN neurons with rotenone,
neuronal death was analyzed by performing MTT assay. Brieﬂy, SN
neurons were incubated with 0.2 mg/ml 3-(4,5-dimetylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) for 2 h at 37 °C. Subsequent-
ly, neurons were washed with PBS, and formazan released was
quantiﬁed at 560 nm by using an ELISA plate reader.
2.10. Statistics
All results are expressed as the mean ± SE value of n experiments.
Statistical signiﬁcance among multiple experimental groups was
determined by one-way ANOVA followed by Dunnett's test. Unpaired
Student's t-test (two-tailed) was used to determine the signiﬁcant
difference between two groups of data. A P value b 0.05 was considered
signiﬁcant.
3. Results
3.1. Generation of PINK1−/− mice
Mouse PINK1 gene contains eight exons. To generate homozygous
mice lacking the expression of PINK1 mRNA (PINK1−/− mice),
homologous recombinationwas targeted on the exon 1,which contains
the start codon and initial 387 nucleotides of PINK1 coding sequence
(Fig. 1A). The targeteddeletionmediatedbyhomologous recombination
removes the start codon and the majority of exon 1 (326 nucleotides of
coding sequence), which is expected to result in the absence of PINK1
mRNA expression. Linearized knockout targeting vector containing
PGK-Neo selection cassette (Fig. 1A)was transfected into 129/Svmouse
ES cells. Southern blot analysis was performed to select correctly
targeted ES cell lines. The expected sizes of DNA fragment in wild-type
allele and targeted allele were 16 and 9 kb, respectively. We have
obtained two clones of ES cells with corrected homologous recombina-
tion, and these cell lines were injected into C57BL/6J blastocysts and
used for the generation of chimeric mice, which were then mated with
C57BL/6J mice and bred to obtain F1 heterozygous mutant mice.
Subsequently, F2 homozygous PINK1 knockout mice were obtained by
the interbreeding of F1 heterozygous mice. Southern blot analysis
Fig. 1. Generation of PINK1-deﬁcient mice. (A) Knockout vector targeting the exon 1 of PINK gene is composed of the short 5′ homologous sequence, PGK-Neo selection cassette and
the long 3′ homologous sequence. Following the homologous recombination, the exon 1 is replaced by PGK-Neo selection cassette. (B) For the Southern blot analysis, tail genomic
DNA prepared from wild-type (+/+), heterozygous PINK1+/− or homozygous PINK1−/− mice was digested with XbaI and hybridized with a 3′ DNA probe. The expected sizes of
DNA fragment in wild-type allele and targeted allele are 16 and 9 kb, respectively. (C) Northern blot analysis using brain total RNA of wild-type mouse detected an expected 2.3 kb
PINK1 mRNA, which was greatly decreased in PINK1+/− mouse and absent in PINK1−/− mouse.
Fig. 2. Cultured substantia nigra dopaminergic neurons of wild-type or PINK1−/−mouse.
(A) RT-PCR analysis demonstrated that in contrast to neuronal culture of substantia nigra
(SN) or neocortex (CTX) prepared from wild-type mouse, PINK1 mRNA was absent in
cultured substantia nigra or neocortical neurons of PINK1−/− mouse. (B) Multipolar or
oval tyrosine hydroxylase-positive dopaminergic neurons were found in primary SN
neuronal culture prepared from wild-type or PINK1−/−mouse. Scale bar is 25 μm.
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transmission of targeted allele in heterozygous PINK1+/− and homo-
zygous PINK1−/−mice.
The successful generation of homozygous PINK1−/− mice was
further conﬁrmed by Northern blot analysis. In contrast to wild-type
or heterozygous PINK1+/−mouse, an expected 2.3 kb PINK1mRNAwas
absent in the brain of homozygous PINK1−/− mouse (Fig. 1C). RT-PCR
analysis also demonstrated that in contrast to wild-type mouse, PINK1
mRNA was absent in the brain or heart of PINK1−/− mouse (data not
shown).
3.2. PINK1 is required for maintaining normal mitochondrial membrane
potential (ΔΨm) of SN dopaminergic neurons, and PARK6 PINK1 mutants
are defective in maintaining ΔΨm
Hyperpolarized mitochondrial membrane potential, which is the
driving force behind oxidative phosphorylation and ion transportation,
plays an important role in the normal function of mitochondria [17,33].
We hypothesized that PINK1 is required for maintaining mitochondrial
membranepotential of SNdopaminergicneuronsand thatPARK6PINK1
mutations impair the ability of PINK1 to maintain mitochondrial
potential. This hypothesis was tested by performing confocal imaging
of mitochondrial membrane potential using wild-type or PINK1−/−
dopaminergic neurons.
Cultured SN dopaminergic neurons are the ideal preparation for
performing the confocal imaging of mitochondria function andmorphol-
ogy and investigating functional consequence of PARK6 PINK1 mutation
following recombinant adenoviruses-mediated overexpression of wild-
type or mutant PINK1 protein. In the present study, primary neuronal
culture of SN was prepared from wild-type or PINK1−/− mice. RT-PCR
analysis showed that in contrast to SN neuronal culture of wild-type
mouse, PINK1 mRNA was absent in cultured SN neurons of PINK1−/−
mouse (Fig. 2A). In accordance with our previous study [31], two
subpopulations of neurons, large multipolar or oval-shaped tyrosine
hydroxylase (TH)-positive dopaminergic cells (diameter = 25–30 μm)
(Fig. 2B) and small non-dopaminergic cells (diameter=15–20 μm),were
found in SNneuronal culture prepared fromwild-type or PINK1-deﬁcient
mouse. Cultured SN neurons prepared from wild-type and PINK1-nullmice contained 37±4% (n=7experiments) and 36±3% (n=7)of TH-
positive dopaminergic cells, respectively. The number of TH-positive
dopaminergic neurons in 6- to 7-day-old SN culture of PINK1−/−mouse
Fig. 4. Expression of wild-type and PARK6 mutant PINK1 in the mitochondria of
cultured PINK1-deﬁcient SN neurons. Three days after the infecting cultured PINK1-
deﬁcient SN dopaminergic neurons with recombinant adenoviruses containing cDNA of
HA-tagged wild-type or PARK6mutant PINK1, subcellular fractionation and subsequent
immunoblotting analysis using anti-HA antibody indicated that wild-type, (G309D),
(E417G) or (CΔ145) PINK1was highly expressed in themitochondrial extract of PINK1-
null SN neurons. Cytochrome-c oxidase subunit IV (COX-IV) was used as an internal
control for mitochondrial fraction.
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experiments).
Confocal imaging of TMRM ﬂuorescence was performed to visualize
hyperpolarizedmitochondrial membrane potential (ΔΨm) of wild-type
or PINK1-deﬁcient SN dopaminergic neurons at 6–7 days in culture,
which were easily identiﬁed by their large diameter (N25 μm), thick
proximal dendrite andmultipolar or oval-shaped cell body (Fig. 3) [31].
The selective accumulation of cationic dye TMRM in themitochondria of
health cell is driven by hyperpolarized mitochondrial membrane
potential. Therefore, TMRM ﬂuorescence intensity is an indicator of
hyperpolarized ΔΨm. Compared to wild-type SN dopaminergic cells,
TMRM ﬂuorescent intensity was signiﬁcantly reduced in PINK1−/− SN
dopaminergic neurons, indicating that PINK1 deﬁciency results in a
depolarized mitochondrial membrane potential (Fig. 3).
To further conﬁrm the essential role of PINK1 inmaintainingΔΨm of
SNdopaminergic neurons and test thehypothesis that PARK6mutations
cause the loss-of-function of PINK1 in regulating ΔΨm, HA-tagged
human wild-type and PARK6 PINK1mutants, (G309D) PINK1, (E417G)
PINK1 and C-terminal truncated (CΔ145) PINK1 (the number repre-
sents amino acid residues deleted from the C-terminal end) [2,4], were
overexpressed in the mitochondria of cultured PINK1−/− SN dopami-
nergic neurons with the aid of recombinant adenoviruses [29,30].
Consistent with our previous study [14], subcellular fractionation and
subsequent Western blot study using anti-HA antiserum indicated that
3 days after the infection of recombinant adenoviruses containing cDNA
of wild-type or mutant PINK1, HA-tagged wild-type PINK1, PARK6
mutant (G309D) or (E417G) PINK1 (M.W. = ~65 kDa) was mainly
expressed in themitochondrial fraction of PINK1-null SN dopaminergic
neurons (Fig. 4) with a minimal expression in the cytosol. When
cultured SN neurons were infected with adenoviruses containing the
cDNA of (CΔ145) PINK1, molecular weight of C-terminal truncated
(CΔ145) PINK1 expressed in themitochondria was reduced to ~48 kDa
(Fig. 4).
When overexpressed in 6- to 7-day-old SN neuronal culture of
PINK1−/− mice, wild-type PINK1 increased TMRM ﬂuorescence
intensity and restored normal ΔΨm of PINK1-deﬁcient SN dopami-
nergic neurons (Fig. 5). As a control, infection of adenoviruses
containing cDNA of GFP or wild-type ataxin-3-Q22 did not affect
TMRM signal and mitochondrial membrane potential of PINK1-null
SN dopaminergic cells (data not shown; n = 4 cells). In contrast to
wild-type PINK1, PARK6 mutant (G309D), (E417G) or (CΔ145) PINK1
was defective in increasing TMRM ﬂuorescence signal and reversing
depolarized ΔΨm of PINK1-deﬁcient SN dopaminergic cells (Fig. 5).
These results indicate that PARK6 mutations cause the impairment of
PINK1 in maintaining the mitochondrial membrane potential.Fig. 3. PINK1 deﬁciency causes a reduction in mitochondrial membrane potential of S
hyperpolarized mitochondrial membrane potential (ΔΨm) of a multipolar wild-type or PINK
decreased in a PINK1-deﬁcient SN dopaminergic cell. Scale bar is 10 μm. (B) A reduction in TM
dopaminergic neurons. Each bar shows the mean ± SE value of 45–50 neurons. *P b 0.01.3.3. PINK1 deﬁciency leads to mitochondrial fragmentation in SN
dopaminergic neurons, which is rescued by wild-type PINK1 but not
by PARK6 mutant PINK1
To investigate PINK1 regulation of mitochondrial morphology,
confocal Mitotracker Green staining was performed to visualize the
mitochondria of 6- to 7-day-old cultured wild-type or PINK1−/− SN
dopaminergic neurons. In the majority (~95%) of wild-type SN
dopaminergic neurons, mitochondria displayed a normal long thread-
like tubular structure (Fig. 6A and B). Fragmented mitochondria, which
are truncated and shortened (b1.5 μm), were only found in about 5% of
wild-type dopaminergic cells (Fig. 6B). On the other hand, the
percentage of dopaminergic neurons (42 ± 4%; n = 5 experiments)
with fragmentedmitochondriawasgreatly increased inPINK1-deﬁcient
SN neuronal culture (Fig. 6A and B). This ﬁnding suggests that PINK1 is
required for maintaining the normal morphology and structural
integrity of mitochondria in SN dopaminergic neurons.
Following the infection of recombinant adenoviruses containing
the cDNA of wild-type PINK1, long thread-like morphology of
mitochondria was restored in PINK1-deﬁcient dopaminergic neurons,
and the number of PINK1-null dopaminergic cells with mitochondrial
fragmentation was signiﬁcantly decreased in PINK1−/− SN neuronal
culture (Fig. 6A and B). In contrast, overexpression of PARK6 mutant
(G309D), (E417G) and (CΔ145) PINK1 failed to signiﬁcantly decrease
the percentage of PINK1-deﬁcient dopaminergic cells with fragmen-
ted mitochondria (Fig. 6A and B). Therefore, PARK6 mutations causeN dopaminergic neurons. (A) Confocal TMRM staining was performed to visualize
1−/− SN dopaminergic neuron. Note that TMRM ﬂuorescence intensity was signiﬁcantly
RM ﬂuorescence intensity and depolarization of ΔΨmwas observed from PINK1−/− SN
Fig. 5. PARK6mutant PINK1 fails to restore the mitochondrial membrane potential in PINK1-deﬁcient SN dopaminergic neurons. (A) Compared to reduced TMRM ﬂuorescence intensity
and depolarized ΔΨm observed in an oval-shaped PINK1−/− dopaminergic neuron, overexpression of wild-type PINK1 (+PINK1) increased TMRM ﬂuorescence intensity and restored
hyperpolarizedΔΨm in amultipolar PINK1-null dopaminergic cell. In contrast, PARK6mutant (G309D), (E417G) or (CΔ145) PINK1was defective in enhancing TMRM ﬂuorescence signal
and reversing depolarized ΔΨm of PINK1−/− SN dopaminergic neurons. Scale bar is 7 μm. (B) In contrast to wild-type PINK1, mutant (G309D), (E417G) and (CΔ145) PINK1 did not
signiﬁcantly increase TMRM ﬂuorescence intensity in PINK1-deﬁcient SN dopaminergic cells. Each bar represents themean± SE value of 45–50 neurons. *P b 0.01 compared to PINK1−/−
dopaminergic neurons.
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morphology of SN dopaminergic neurons.
3.4. PINK1 deﬁciency enhances ROS generation in SN dopaminergic
neurons, which is reversed by wild-type PINK1 but not by PARK6 mutant
PINK1
Mitochondrial electron transport chain is the major intracellular
source of reactive oxygen species (ROS), including superoxide anion,
hydroxyl radical, various peroxides and hydroperoxides [34]. An
excessive ROS formation and resulting oxidative stress is believed to
be involved in PD pathogenesis [18–20]. It is very likely that PINK1
protects SN dopaminergic neurons from oxidative stress-induced
neurotoxicity by inhibiting ROS formation. According to this hypothesis,
mitochondrial ROS generation and oxidative stress inducer-evoked
intracellular ROSproduction are expected to beaugmented in PINK1−/−
SN dopaminergic cells.
In the present study, confocal MitoSOX Red staining was performed
to visualize mitochondrial level of superoxide anion, a major ROS
produced by the mitochondria, in 6- to 7-day-old cultured wild-type or
PINK1-deﬁcient SN dopaminergic neurons. MitoSOX Red is selectively
targeted to themitochondria and exhibits redﬂuorescence following theoxidation by superoxide anion. Compared towild-type SNdopaminergic
cells, MitoSOX Red ﬂuorescence intensity, an indicator of mitochondrial
superoxide level, was signiﬁcantly increased in PINK1−/− dopaminergic
neurons (Fig. 7). Following the overexpression of wild-type PINK1,
ﬂuorescence signal of MitoSOX Red and mitochondrial superoxide
generation was greatly reduced in PINK1-deﬁcient SN dopaminergic
cells (Fig. 7). In contrast, infecting PINK1-null SN dopaminergic neurons
with recombinant adenoviruses containing the cDNA of PARK6 mutant
(G309D), (E417G) or (CΔ145) PINK1 was defective in decreasing
mitochondrial level of superoxide (Fig. 7).
Confocal CM-H2DCFDA staining was performed to visualize oxida-
tive stressor H2O2-induced intracellular ROS generation in wild-type or
PINK1-deﬁcient SN dopaminergic neurons. CM-H2DCFDA, a cell-
permeant ROS indicator, is nonﬂuorescent and then converted to highly
ﬂuorescent 2′,7′-dichloroﬂuorescein (DCF) following the removal of the
acetate groups by intracellular esterases and ROS-induced oxidation
(Fig. 8A and B). Compared to wild-type SN dopaminergic cells, H2O2 (1
mM)-induced DCF ﬂuorescence and ROS formation was greatly
augmented in PINK1−/− dopaminergic neurons (Fig. 8A and B). After
the infection of adenoviruses containing the cDNA of wild-type PINK1,
oxidative stressorH2O2 (1mM)-evokedDCFﬂuorescence signal andROS
production was signiﬁcantly attenuated in PINK1-deﬁcient SN
Fig. 6. PINK1 deﬁciency promotesmitochondrial fragmentation in SN dopaminergic cells, which is rescued bywild-type PINK1 but not by PARK6mutant PINK1. (A) ConfocalMitotracker
Green stainingwasperformed tovisualizemitochondrialmorphology. In contrast toﬁlamentous and long thread-likemitochondria of a representativewild-type SNdopaminergic neuron,
fragmented and shortened (b1.5 μm) mitochondria were observed from a PINK1−/− dopaminergic cell. Overexpression of wild-type PINK1 restored long thread-like morphology of
mitochondria in a PINK1-deﬁcient dopaminergic neuron. Fragmented mitochondria were still observed in PINK1-null SN dopaminergic cells overexpressing PARK6 mutant (G309D),
(E417G) or (CΔ145) PINK1. Scale bar is 4 μm. (B) Percentage of dopaminergic neuronswith fragmentedmitochondrial was greatly increased in PINK1−/− SNneuronal culture. In contrast
to wild-type PINK1, mutant (G309D), (E417G) and (CΔ145) PINK1 failed to rescue mitochondrial fragmentation in PINK1-deﬁcient dopaminergic neurons. In each experiment,
mitochondrial morphology of 20 wild-type or PINK1-null dopaminergic neurons was analyzed using the LAS AF software. For each dopaminergic cell, lengths of 30 well separated
mitochondriaweremeasured.Dopaminergicneuronwas deﬁnedas thecellwithmitochondrial fragmentationwhen≥10%ofmitochondriameasuredwere truncated and shortened(b1.5
μm). Each bar represents the mean ± SE value of 5 experiments. *P b 0.01 compared to wild-type dopaminergic neurons. #P b 0.01 compared to PINK1−/− dopaminergic neurons.
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overexpression of PARK6 mutant (G309D), (E417G) or (CΔ145) PINK1
failed to signiﬁcantly inhibit H2O2-induced DCF ﬂuorescence and ROS
generation in PINK1-null dopaminergic neurons (Fig. 8B and C). These
ﬁndings suggest that lack of functional PINK1 expression caused by
PARK6 mutations could augment the vulnerability of dopaminergic
neurons to oxidative stress-induced neurotoxicity.
3.5. PINK1 deﬁciency enhances rotenone-induced cell death in SN neuronal
culture
Thepesticide rotenone is an inhibitor ofmitochondrial complex I and
induces cell death of SN dopaminergic neurons by causing oxidative
stress. Rotenone has been proposed to act as an environmental
mitochondrial toxin involved in PD pathogenesis and used to prepare
PD animalmodel [18,20]. Our results demonstrate that PINK1deﬁciency
in SN dopaminergic cells leads to depolarization of mitochondrial
membrane potential and elevatedmitochondrial ROS generation,which
is likely to enhance the susceptibility of dopaminergic neurons tomitochondrial toxin rotenone. In accordance with this hypothesis, MTT
assays indicated that compared to 6- to 7-day-old wild-type neuronal
cultureof SN, rotenone-induced cell death of dopaminergic neuronswas
signiﬁcantly enhanced in PINK1-deﬁcient SN neuronal culture (Fig. 9A).
Following the overexpression of wild-type PINK1, augmentation of
rotenone (150 nM)-induced cell death was signiﬁcantly prevented in
PINK1−/− SN neuronal culture (Fig. 9B). In contrast, infecting PINK1-
null SNneuronswith recombinant adenoviruses containing the cDNAof
mutant (G309D), (E417G) or (CΔ145) PINK1 did not inhibit enhance-
ment of rotenone-induced neuronal death (Fig. 9B).
4. Discussion
Missense or truncating mutations of PINK1 gene cause recessive
familial type6 of Parkinson's disease (PARK6) [2–6]. PINK1 is believed to
function as a mitochondrial Ser/Thr protein kinase and protect SN
dopaminergic neurons against various cellular stresses [2,7,13,16].
Autosomal recessive inheritance mode indicates that PARK6 mutation-
induced loss of PINK1 function is involved in the pathogenesis of PARK6.
Fig. 7. PINK1 deﬁciency in SN dopaminergic neurons enhancesmitochondrial superoxide
formation, which is inhibited by wild-type PINK1 but not by PARK6 mutant PINK1.
ConfocalMitoSOXRed stainingwas performed to visualize the basal level ofmitochondrial
superoxide. MitoSOX Red ﬂuorescence intensity and the formation of mitochondrial
superoxidewas signiﬁcantly augmented in PINK1−/− SNdopaminergic neurons. Infecting
PINK1-null dopaminergic cells with recombinant adenoviruses containing the cDNA of
wild-type PINK1greatly inhibitedMitoSOXRed signal andmitochondrial superoxide level.
Overexpression of PARK6 mutant (G309D), (E417G) or (CΔ145) PINK1 was defective in
inhibiting MitoSOX Red ﬂuorescence intensity in PINK1-deﬁcient SN dopaminergic
neurons. Each bar represents themean±SEvalue of 25–30neurons. *Pb 0.01 compared to
wild-typedopaminergicneurons.#Pb0.01 compared toPINK1−/−dopaminergicneurons.
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expressed in cell lines, PARK6 PINK1 mutants lose the ability to inhibit
mitochondrial release of cytochrome-c and exert anti-apoptotic effect
[2,14,30]. PINK1 is the ﬁrst protein directly linking the mitochondrial
abnormality to the neurotoxicity of SN dopaminergic cells and PD
pathogenesis. Therefore, it is essential to study PINK1 regulation of
mitochondrial functions and PARK6 mutations-induced loss of PINK1
function in SN dopaminergic neurons.
In thepresent study,weprepared PINK1knockoutmousebydeleting
the exon 1 of PINK1 gene with the aid of homologous recombination.
Previously, homologous recombination-mediated targeting exons 4–7,
exons 3–5 or exons 4–5 has also been successfully performed to prepare
PINK1-deﬁcient mice [35–37]. Cultured SN dopaminergic neurons are
the ideal preparation for conducting confocal imaging of mitochondria
function and morphology and studying functional consequence of
PARK6 mutation following recombinant adenoviruses-mediated over-
expression of wild-type or PARK6mutant PINK1. Thus, cultured PINK1-
deﬁcient SN dopaminergic cells were used to investigate physiological
importance of PINK1 in maintaining mitochondrial function and
morphology and test the hypothesis that PARK6 mutations cause the
loss of PINK1 function in SN dopaminergic neurons.
Confocal imaging of potential sensitive dye TMRM indicated that a
depolarized mitochondrial membrane potential (ΔΨm) was observed
from PINK1−/− SN dopaminergic neurons. Overexpression of wild-type
PINK1 restored mitochondrial membrane potential of PINK1-null SN
dopaminergic cells. In contrast, PARK6 mutant (G309D), (E417G) or C-
terminal truncated (CΔ145) PINK1 failed to signiﬁcantly reverse
depolarized ΔΨm observed in PINK1-deﬁcient SN dopaminergic
neurons. These ﬁndings suggest that PINK1 is required for maintaining
normal mitochondrial membrane potential of SN dopaminergic cells
and that PARK6 mutations-induced loss of PINK1 function could cause
mitochondrial dysfunction of SN dopaminergic neurons by depolarizing
mitochondrial membrane potential.
The number of dopaminergic cells with truncated and shortened
mitochondria was greatly increased in PINK1-null SN neuronal culture.
Following an overexpression of wild-type PINK1, long thread-like
morphology of mitochondria was restored in PINK1-deﬁcient dopami-
nergic cells. On the other hand, PARK6 mutant (G309D), (E417G) or
(CΔ145) PINK1 was defective in rescuing mitochondrial fragmentationin PINK1−/− dopaminergic neurons. Our results suggest that PINK1 is
required for maintaining the normal morphology and structural
integrity of mitochondria in SN dopaminergic neurons and that PARK6
mutations cause the loss of PINK1 function in controllingmitochondrial
morphology.
Mitochondria form dynamic tubular networks that undergo fre-
quent morphological changes through ﬁssion and fusion, and dysregu-
lated process of mitochondrial ﬁssion/fusion is believed to affect
neuronal survival and function [38,39]. Three mitochondrial proteins,
mitofusin 1 (MFN1), mitofusin 2 (MFN2) and optic atrophy 1 (OPA1),
are required for mitochondrial fusion in mammals. Mitochondrial
ﬁssion in mammalian cells is mediated by dynamin-related protein 1
(Drp1) [38,39]. Cycles of mitochondrial ﬁssion and fusion allow
metabolite and mitochondrial DNA mixing and are required for
maintaining shape, number and bioenergetic functionality of mito-
chondria [38,40]. PINK1 deﬁciency-induced mitochondrial fragmenta-
tion in SN dopaminergic neurons may result from an excessive
mitochondrialﬁssionor a defectivemitochondrial fusion.Recent studies
showed that knockdown of Drp1, dominant negative Drp1 and
overexpression of MFN2 or OPA1 prevented PINK1 deﬁciency-induced
mitochondrial fragmentation in SH-SY5Y neuroblastoma cells [27,41].
Furthermore, PINK1 knockdown fails to cause mitochondrial fragmen-
tation in Drp1-deﬁcient SH-SY5Y cells [26]. These ﬁndings suggest that
PINK1 regulates mitochondrial ﬁssion process by modulating Drp1
function and that mitochondrial fragmentation observed in PINK1-
deﬁcient cells results from an augmented mitochondrial ﬁssion.
Mitochondrial fragmentation caused by persistent ﬁssion has been
proposed to promote apoptotic neuronal death [38,39]. Thus, it is
possible thatPINK1deﬁciencyorPARK6mutation-induced lossof PINK1
function could cause neurotoxicity of SN dopaminergic cells by
augmenting mitochondrial ﬁssion. Further study is required to
investigate the exact molecular mechanism by which PINK1 regulates
mitochondrial ﬁssion/fusion of SN dopaminergic neurons.
Recent studies using cell lines reported that in addition to regulating
mitochondrial membrane potential and morphology, PINK1 is also
required for the clearance of damaged mitochondria via autophagy—a
process known as mitophagy [42]. PINK1 kinase activity and its
mitochondrial localization sequence are prerequisites to induce
translocation of the E3 ligase parkin to depolarized mitochondria and
subsequent parkin-dependent autophagic degradation of damaged
mitochondria [43]. PARK6 (G309D), (E417G) and (CΔ145) mutations
investigated in this study are likely to impair PINK1/parkin-mediated
mitophagy and cause anaccumulation of damagedmitochondria,which
may contribute to PD pathogenesis. PINK1-deﬁcient SN dopaminergic
cells prepared by us should be a valuable tool to investigate
physiological and pathological importance of PINK1/parkin-mediated
mitophagy in SN dopaminergic neurons.
Our results demonstrated that both basal level of mitochondrial
superoxide and oxidative stressor H2O2-induced ROS generation were
greatly increased in PINK1-null SN dopaminergic neurons. PINK1
deﬁciency-induced ROS formation and oxidative stress is expected to
cause depolarization of mitochondrial membrane potential and mito-
chondrial fragmentation [18,20,38]. Overexpression of wild-type PINK1
inhibited mitochondrial superoxide generation and oxidative stressor
H2O2-induced ROS production in PINK1-deﬁcient SN dopaminergic cells.
In contrast, PARK6 mutant (G309D), (E417G) or (CΔ145) PINK1
was defective in decreasing mitochondrial level of superoxide and
H2O2-inducedROSgeneration inPINK1−/−dopaminergic neurons. These
ﬁndings suggest that PINK1 exerts a neuroprotective effect on SN
dopaminergic cells by attenuating ROS formation and oxidative stress
and that PARK6mutations-induced loss of PINK1 function could augment
the vulnerability of dopaminergic neurons to oxidative stress-induced
neurotoxicity. In accordance with our ﬁndings, ﬁbroblasts and immor-
talized lymphoblast prepared from PD patients with (G309D) and
(W437X) PINK1 mutations displayed an increased oxidative damage
when compared with cells from control individuals [44,45].
Fig. 8. PINK1 deﬁciency augments H2O2-induced ROS formation in SN dopaminergic neurons, which is prevented bywild-type PINK1 but not by PARK6mutant PINK1. (A) Confocal CM-
H2DCFDA imaging indicated that pretreating anoval-shapedwild-type dopaminergic neuronwith oxidative stressor H2O2 (1mM) for 30min induced intracellular ROS formation andDCF
ﬂuorescence. (B) H2O2-induced increase in ROS production and DCF ﬂuorescence was signiﬁcantly augmented in a PINK1−/− SN dopaminergic cell. Overexpression of wild-type PINK1
greatly reduced H2O2-evoked ROS generation and DCF ﬂuorescence signal in a PINK1-deﬁcient dopaminergic neuron. In contrast, infecting PINK1−/− SN dopaminergic cells with
adenoviruses containing the cDNA of PARK6 mutant (G309D), (E417G) or (CΔ145) PINK1was defective in reducing H2O2-induced DCF ﬂuorescence. Scale bar is 10 μm. (C) Summary of
H2O2 (1mM)-induced DCF ﬂuorescence inwild-type dopaminergic neurons, PINK−/− dopaminergic cells and PINK1-deﬁcient dopaminergic neurons overexpressingwild-type or PARK6
mutant PINK1. Each bar represents the mean± SE value of 25 neurons. *P b 0.01 compared to wild-type dopaminergic neurons. #P b 0.01 compared to PINK1−/− dopaminergic neurons.
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morphology and function aspects of mitochondria in the striatum of
adult PINK1−/− mice [46]. In accordance with our ﬁndings, mitochon-
drial dysfunction and enhanced oxidative stress were observed in adult
PINK1-deﬁcient mice [46]. Our study shows that mitochondria
fragmentation is greatly increased in cultured PINK1-null dopaminergic
neurons. However, electron microscopic studies did not ﬁnd gross
change in the ultrastructure or the total number of mitochondria in the
striatum of adult PINK1-deﬁcientmice [46]. This discrepancy is likely to
result from PINK1 deﬁciency-induced region speciﬁc effect (substantia
nigra versus striatum) or unknown compensatory mechanism(s) in
adult PINK1−/−mice.The complex I ofmitochondrial electron transport chain is thought to
be the main source of ROS formation, and an impaired activity of
mitochondrial complex I increases ROS generation and causes resulting
oxidative stress [17,34]. A deﬁciency inmitochondrial complex I activity
was found in the SN of PD patients [18–20]. Interestingly, reduced
activity of mitochondrial complex I was also observed in cultured
ﬁbroblasts prepared fromPARK6patients [47]. The pesticide rotenone is
an inhibitor of mitochondrial complex I and induces cell death of SN
dopaminergic neurons by causing oxidative stress. PINK1 deﬁciency-
induced depolarization of mitochondrial membrane potential and
elevated ROS formation is likely to enhance the susceptibility of SN
dopaminergic neurons tomitochondrial toxin rotenone. Consistentwith
Fig. 9. PINK1deﬁciency enhances rotenone-induced cell death of cultured SNneurons. (A)
Mitochondrial neurotoxin rotenone induced cell death of wild-type cultured SN neurons
with a dose-dependent manner. Compared to wild-type SN neuronal culture, rotenone-
induced cell death of dopaminergic neurons was signiﬁcantly augmented in PINK1-
deﬁcient SN neuronal culture. (B) Overexpression of wild-type PINK1 signiﬁcantly
prevented the augmentation of rotenone (150 nM)-induced cell death in PINK1−/− SN
neuronal culture. Augmented rotenone-induced neuronal death was still observed in
PINK1-null SN neurons overexpressing PARK6 mutant (G309D), (E417G) or (CΔ145)
PINK1. Each bar shows the mean ± SE value of 4–5 experiments. *P b 0.01 compared to
wild-type cultured SN neurons. #P b 0.01 compared to cultured PINK1−/− SN neurons.
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was signiﬁcantly enhanced in PINK1-deﬁcient SN neuronal culture.
Our study suggests that PINK1 exerts neuroprotective effect on
cultured SN dopaminergic cells. The absence of functional PINK1 could
lead to neurotoxicity of SN dopaminergic cells and resulting parkinson-
ism. A recent post-mortem neuropathological examination of an early-
onset PARK6 patient, a carrier of two heterozygous compound PINK1
mutations, reported neuronal loss in the substantia nigra pars compacta
[48]. The present study shows that PINK1 deﬁciency enhances the
vulnerability of SN dopaminergic cells to mitochondrial toxin rotenone.
However, the number of TH-positive dopaminergic neurons in SN
culture of PINK1−/−mousewas similar to that in SNneuronal culture of
wild-type mouse. Neuronal loss of SN dopaminergic cells and PARK6
motor dysfunction was not observed in 6- to 9-month-old PINK1-
deﬁcient mice prepared by us (data not shown). Similar to our results,
previous TH-staining study using adult PINK1−/− mice, generated by
targeting deletion of exons 4–7 or exons 4–5 of PINK1 gene, showed no
abnormality in morphology and number of SN dopaminergic neurons
[35,36]. The absence of dopaminergic neuronal loss in the SNand PARK6
neurological phenotype in adult PINK1-null mice could result from
several possible mechanisms, including the redundancy of mitochon-
drial Ser/Thr protein kinases, the lack of appropriate environmental
triggers, functional compensation or species-dependent PINK1 function.
In summary, our results indicate that wild-type PINK1 is required
for maintaining hyperpolarized mitochondrial membrane potentialand normal mitochondrial morphology and inhibits ROS formation of
cultured SN dopaminergic neurons. The present study further
provides the ﬁrst evidence that PARK6 mutant (G309D), (E417G) or
(CΔ145) PINK1 is defective in attenuating ROS production and
maintaining mitochondrial membrane potential and morphology of
SN dopaminergic neurons. Wild-type PINK1 is believed to function as
a mitochondrial Ser/Thr protein kinase, suggesting that PINK1
maintains mitochondrial membrane potential, regulates mitochon-
dria ﬁssion/fusion and inhibits ROS generation by phosphorylating
mitochondrial proteins of SN dopaminergic neurons. PARK6 mutant
(G309D), (E417G) and (CΔ145) PINK1 studied in the present study
are found in the Ser/Thr kinase domain of PINK1 and believed to cause
an impairment of Ser/Thr kinase activity [11,12,49]. Therefore, it is
very likely that an impaired Ser/Thr kinase activity caused by PARK6
(G309D), (E417G) and (CΔ145) mutations results in the loss of
PINK1-mediated mitochondrial functions. A previous study reported
that PINK1 inhibits oxidative stress-induced apoptotic cell death by
phosphorylating mitochondrial chaperone TRAP1 [15]. Further quan-
titative phosphoproteomic analysis is required to identify other
putative mitochondrial substrates of PINK1 and investigate the
molecular mechanisms of PINK1 phosphorylation-mediated neuro-
protective effects in SN dopaminergic cells.
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